Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Episurf Medical AB (publ)    EPIS B   SE0003491562

EPISURF MEDICAL AB (PUBL)

(EPIS B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Episurf Medical : enters into a distribution agreement for additional markets in Asia

10/15/2020 | 02:31am EST

Episurf Medical (Nasdaq: EPIS B) today announces that the company has entered into a distribution agreement with Humedical (S) Pte Ltd. The agreement covers the markets in Singapore, Malaysia, and Brunei. Episurf Medical is currently working with obtaining regulatory clearances in said markets, and these processes are expected to be completed during the first quarter of 2021.  

Humedical (S) Pte Ltd has for 25 years been operating as a supplier to a significant part of the hospitals in the region, focusing on surgery, including orthopaedics.  

"We are happy to be able to enter into a partnership with such an experienced and well-established distributor as Humedical, as we are systematically preparing for product launch in new markets in Asia" says Pål Ryfors, CEO Episurf Medical.  

Episurf Medical has since before a distributor agreement in place for Hong Kong.  

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical's Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.

https://news.cision.com/episurf/r/episurf-medical-enters-into-a-distribution-agreement-for-additional-markets-in-asia,c3216375

https://mb.cision.com/Main/14691/3216375/1319319.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English

All news about EPISURF MEDICAL AB (PUBL)
11/30EPISURF MEDICAL : Episealer® presentation at the Combined Bristol & Oxford Unico..
AQ
11/27EPISURF MEDICAL : enters into international advisory agreement
AQ
11/26EPISURF MEDICAL : carries out a directed share issue and raises proceeds of SEK ..
AQ
11/13EPISURF MEDICAL : First Episealer® surgery in Scotland performed
AQ
11/04EPISURF MEDICAL : First Episealer® Talus surgery in Scandinavia performed
AQ
10/26DNB MARKETS - EPISURF MEDICAL :  Clinical data strengthens the case
AQ
10/26EPISURF MEDICAL : First Episealer® surgery performed in Asia
AQ
10/23EPISURF MEDICAL : Interim Report 1 July - 30 September 2020
AQ
10/15EPISURF MEDICAL : enters into a distribution agreement for additional markets in..
AQ
10/14EPISURF MEDICAL : Members of the Nomination Committee for Episurf Medical's Annu..
AQ
More news
Financials
Sales 2020 6,00 M 0,71 M 0,71 M
Net income 2020 -72,8 M -8,62 M -8,62 M
Net cash 2020 81,0 M 9,60 M 9,60 M
P/E ratio 2020 -5,67x
Yield 2020 -
Capitalization 419 M 49,6 M 49,6 M
EV / Sales 2020 56,4x
EV / Sales 2021 35,2x
Nbr of Employees 25
Free-Float 89,1%
Chart EPISURF MEDICAL AB (PUBL)
Duration : Period :
Episurf Medical AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EPISURF MEDICAL AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price 4,00 SEK
Last Close Price 2,27 SEK
Spread / Highest target 76,6%
Spread / Average Target 76,6%
Spread / Lowest Target 76,6%
EPS Revisions
Managers
NameTitle
Pål Ryfors Chief Executive Officer
Dennis D. Stripe Chairman
Katarina Flodstrom Chief Operating & Regulatory Officer
Veronica Wallin Chief Financial Officer
Leif Erik Sigfrid Ryd Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EPISURF MEDICAL AB (PUBL)97.01%50
STRYKER CORPORATION11.58%88 033
SMITH & NEPHEW PLC-18.14%17 516
INSPIRE MEDICAL SYSTEMS, INC.158.05%5 158
VENUS MEDTECH (HANGZHOU) INC.99.33%4 016
GLAUKOS CORPORATION27.67%3 125